mutLBSgeneDB |
Gene summary for IFNA2 |
Gene summary |
Basic gene Info. | Gene symbol | IFNA2 |
Gene name | interferon, alpha 2 | |
Synonyms | IFN-alphaA|IFNA|IFNA2B|INFA2 | |
Cytomap | UCSC genome browser: 9p22 | |
Type of gene | protein-coding | |
RefGenes | NM_000605.3, | |
Description | IFN-alpha-2alpha-2a interferoninterferon alpha 2ainterferon alpha 2binterferon alpha Ainterferon alpha-2leIF A | |
Modification date | 20141207 | |
dbXrefs | MIM : 147562 | |
HGNC : HGNC | ||
Ensembl : ENSG00000188379 | ||
HPRD : 00950 | ||
Vega : OTTHUMG00000019674 | ||
Protein | UniProt: P01563 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_IFNA2 | |
BioGPS: 3440 | ||
Pathway | NCI Pathway Interaction Database: IFNA2 | |
KEGG: IFNA2 | ||
REACTOME: IFNA2 | ||
Pathway Commons: IFNA2 | ||
Context | iHOP: IFNA2 | |
ligand binding site mutation search in PubMed: IFNA2 | ||
UCL Cancer Institute: IFNA2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0010629 | negative regulation of gene expression | 20554961 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein | 22783022 | GO:0045581 | negative regulation of T cell differentiation | 20554961 | GO:0045892 | negative regulation of transcription, DNA-templated | 20554961 | GO:0046597 | negative regulation of viral entry into host cell | 22783022 | GO:0051607 | defense response to virus | 22783022 | GO:2000552 | negative regulation of T-helper 2 cell cytokine production | 20554961 | GO:2000663 | negative regulation of interleukin-5 secretion | 20554961 | GO:2000666 | negative regulation of interleukin-13 secretion | 20554961 |
Top |
Ligand binding site mutations for IFNA2 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | T129 | T129I | COAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for IFNA2 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | T129 | T129I | 0.025096667 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for IFNA2 from PDB |
Top |
Differential gene expression and gene-gene network for IFNA2 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for IFNA2 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0524910 | Hepatitis C, Chronic | 134 | Biomarker, Therapeutic |
umls:C0019196 | Hepatitis C | 75 | Biomarker, GeneticVariation, Therapeutic |
umls:C0025202 | Melanoma | 31 | Biomarker, GeneticVariation, Therapeutic |
umls:C0524909 | Hepatitis B, Chronic | 25 | Biomarker, Therapeutic |
umls:C0019163 | Hepatitis B | 16 | Biomarker, GeneticVariation, Therapeutic |
umls:C0023473 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 15 | Biomarker, Therapeutic |
umls:C0019189 | Hepatitis, Chronic | 12 | Biomarker, Therapeutic |
umls:C0032463 | Polycythemia Vera | 8 | Biomarker, GeneticVariation, Therapeutic |
umls:C0040028 | Thrombocythemia, Essential | 7 | Biomarker, Therapeutic |
umls:C0002871 | Anemia | 7 | Biomarker |
umls:C0011581 | Depressive Disorder | 5 | Biomarker |
umls:C0023530 | Leukopenia | 5 | Biomarker |
umls:C0007137 | Carcinoma, Squamous Cell | 4 | Biomarker, Therapeutic |
umls:C0026764 | Multiple Myeloma | 4 | Biomarker, Therapeutic |
umls:C0040034 | Thrombocytopenia | 4 | Biomarker |
umls:C0042170 | Uveomeningoencephalitic Syndrome | 4 | Biomarker |
umls:C0002878 | Anemia, Hemolytic | 3 | Biomarker |
umls:C0027497 | Nausea | 3 | Biomarker |
umls:C0007134 | Carcinoma, Renal Cell | 2 | Biomarker, Therapeutic |
umls:C0007138 | Carcinoma, Transitional Cell | 2 | Biomarker, Therapeutic |
umls:C0015672 | Fatigue | 2 | Biomarker |
umls:C0017636 | Glioblastoma | 2 | Biomarker, Therapeutic |
umls:C0019829 | Hodgkin Disease | 2 | Biomarker, Therapeutic |
umls:C0005695 | Urinary Bladder Neoplasms | 2 | Biomarker, Therapeutic |
umls:C0042749 | Viremia | 2 | Biomarker, Therapeutic |
umls:C0015967 | Fever | 2 | Biomarker |
umls:C0023493 | Leukemia-Lymphoma, Adult T-Cell | 2 | Therapeutic |
umls:C0035305 | Retinal Detachment | 2 | Biomarker |
umls:C0042963 | Vomiting | 2 | Biomarker |
umls:C0000737 | Abdominal Pain | 1 | Biomarker |
umls:C2609414 | Acute Kidney Injury | 1 | Biomarker |
umls:C0003123 | Anorexia | 1 | Biomarker |
umls:C0003469 | Anxiety Disorders | 1 | Biomarker |
umls:C0085593 | Chills | 1 | Biomarker |
umls:C0009404 | Colorectal Neoplasms | 1 | Therapeutic |
umls:C0011991 | Diarrhea | 1 | Biomarker |
umls:C0860207 | Drug-Induced Liver Injury | 1 | Biomarker |
umls:C0015695 | Fatty Liver | 1 | Biomarker |
umls:C0206608 | Flavivirus Infections | 1 | Therapeutic |
umls:C0018681 | Headache | 1 | Biomarker |
umls:C0206732 | Hemangioendothelioma, Epithelioid | 1 | Therapeutic |
umls:C0020557 | Hypertriglyceridemia | 1 | Biomarker |
umls:C0021845 | Intestinal Perforation | 1 | Biomarker |
umls:C0023893 | Liver Cirrhosis, Experimental | 1 | Therapeutic |
umls:C0024301 | Lymphoma, Follicular | 1 | Therapeutic |
umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | Therapeutic |
umls:C0025287 | Meningism | 1 | Biomarker |
umls:C0004936 | Mental Disorders | 1 | Biomarker |
umls:C0027051 | Myocardial Infarction | 1 | Biomarker |
umls:C0027947 | Neutropenia | 1 | Biomarker |
umls:C0155305 | Optic Neuropathy, Ischemic | 1 | Biomarker |
umls:C0030193 | Pain | 1 | Biomarker |
umls:C0030297 | Pancreatic Neoplasms | 1 | Therapeutic |
umls:C0033999 | Pterygium | 1 | Therapeutic |
umls:C0034734 | Raynaud Disease | 1 | Biomarker |
umls:C1565489 | Renal Insufficiency | 1 | Biomarker |
umls:C0035309 | Retinal Diseases | 1 | Biomarker |
umls:C0243026 | Sepsis | 1 | Biomarker |
umls:C0037274 | Skin Diseases | 1 | Biomarker |
umls:C0037650 | Somatoform Disorders | 1 | Biomarker |
umls:C0038362 | Stomatitis | 1 | Biomarker |
umls:C0038587 | Substance Withdrawal Syndrome | 1 | Therapeutic |
umls:C0040136 | Thyroid Neoplasms | 1 | Therapeutic |
umls:C0040264 | Tinnitus | 1 | Biomarker |
umls:C0043096 | Weight Loss | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for IFNA2 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of IFNA2 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of IFNA2 |
Multiple alignments for P01563 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |